employer glp-1 coverage news Large employers embrace GLP-1s Your Employer Can Cover Your

This doctor-prescribed and supervised weight loss injection pen is US FDA-approved and works by...

Read the latest issue of The Dairy Bar, a bi-weekly report from IDFA partner Ever.Ag

Massive obesity market opportunity Growing diabetes prevalence globally Potential cardiovascular benefits Expanding applications beyond weight loss Strong commercial performance from current market leaders The success of Ozempic, Wegovy, Mounjaro, and Zepbound has demonstrated that obesity treatment is no longer a niche categoryit is becoming one of the most important therapeutic areas in modern medicine

One of the largest US health insurers is ending coverage of GLP-1 weight-loss drugs for its employees but will continue covering them for people with type 2 diabetes.

Alcohol wipe slot fits single-use prep pads or swabs

Were committed to delivering a high-quality, bioavailable GLP-1 oral solution to help you feel your best every day*